We are live on ! Find out more
Janney Montgomery Scott

Janney Montgomery Scott Portfolio holdings

AUM $40.4B
1-Year Est. Return 21.2%
This Fund
S&P 500
This Quarter Est. Return
+2.5%
1 Year Est. Return
+21.2%
3 Year Est. Return
+63.29%
5 Year Est. Return
+71.3%
10 Year Est. Return
+241.78%
AUM
$6.63B
AUM Growth
+$953M
Cap. Flow
+$855M
Cap. Flow %
12.9%
Top 10 Hldgs %
13.21%
Holding
1,757
New
237
Increased
905
Reduced
493
Closed
79
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENOC
1651
DELISTED
EnerNOC, Inc.
ENOC
$67K ﹤0.01%
+11,199
New +$64.9K
ATAXZ
1652
DELISTED
AMERICA FIRST TAX EXEMT INV LP
ATAXZ
$65K ﹤0.01%
12,000
DHF
1653
BNY Mellon High Yield Strategies Fund
DHF
$170M
$61K ﹤0.01%
18,301
+301
+2% +$987
MIN
1654
Aberdeen Intermediate Income Fund
MIN
$272M
$61K ﹤0.01%
13,769
+955
+7% +$4.2K
SKIS
1655
DELISTED
Peak Resorts, Inc.
SKIS
$60K ﹤0.01%
10,855
-300
-3% -$1.46K
GNW icon
1656
Genworth Financial
GNW
$3.79B
$59K ﹤0.01%
15,543
-4,000
-20% -$17.6K
LUNA
1657
DELISTED
Luna Innovations Incorporated
LUNA
$59K ﹤0.01%
40,000
-2,000
-5% -$2.74K
ADYX
1658
DELISTED
Adynxx Inc
ADYX
$54K ﹤0.01%
1,525
-108
-7% -$4.52K
CEMP
1659
DELISTED
Cempra, Inc.
CEMP
$51K ﹤0.01%
18,100
+150
+0.8% +$1.82K
CHKR
1660
DELISTED
CHESAPEAKE GRANITE WASH TRUST
CHKR
$49K ﹤0.01%
20,900
-500
-2% -$1.1K
SANW
1661
DELISTED
S&W Seed Co
SANW
$48K ﹤0.01%
547
ELON
1662
DELISTED
Echelon Corp
ELON
$48K ﹤0.01%
+10,271
New +$50.7K
SGMO
1663
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$36K ﹤0.01%
11,778
-1,950
-14% -$7.1K
BAC.WS.B
1664
DELISTED
Bank Of America Corporation Ws B
BAC.WS.B
$34K ﹤0.01%
35,000
REXX
1665
DELISTED
Rex Energy Corporation
REXX
$31K ﹤0.01%
6,570
-600
-8% -$2.89K
PDLI
1666
DELISTED
PDL BioPharma, Inc.
PDLI
$24K ﹤0.01%
11,503
-23,355
-67% -$65.2K
ATRS
1667
DELISTED
Antares Pharma, Inc.
ATRS
$23K ﹤0.01%
10,000
ARNA
1668
DELISTED
Arena Pharmaceuticals Inc
ARNA
$23K ﹤0.01%
1,619
-9,591
-86% -$149K
ONCS
1669
DELISTED
OncoSec Medical Incorporated
ONCS
$20K ﹤0.01%
75
+20
+36% +$6.87K
MNKD icon
1670
MannKind Corp
MNKD
$1.22B
$18K ﹤0.01%
5,679
-1,003
-15% -$2.9K
NBSE
1671
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$17K ﹤0.01%
29
-1
-3% -$1.06K
FTEK icon
1672
Fuel Tech
FTEK
$47.4M
$14K ﹤0.01%
12,500
-2,000
-14% -$2.54K
TOVX icon
1673
Theriva Biologics
TOVX
$9.78M
$13K ﹤0.01%
+2
New +$20.5K
VNR
1674
DELISTED
Vanguard Natural Resources, LLC
VNR
$11K ﹤0.01%
16,599
-4,607
-22% -$3.33K
FCSC
1675
DELISTED
Fibrocell Science Inc.
FCSC
$7K ﹤0.01%
+733
New +$7.87K

Similar funds

Janney Montgomery Scott's Q4 2016 Portfolio in Review

As of Q4 2016, Janney Montgomery Scott held 1,757 positions worth $6.63B, up 17% from $5.68B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Janney Montgomery Scott deployed $855M of net new capital in Q4 2016, opening 237 new positions and adding to 905 existing holdings. Its largest new stake was State Street SPDR Portfolio Short Term Corporate Bond ETF: 1,603,784 shares worth $49M.

By sector, the portfolio is most concentrated in Financials at 8.9% of assets, up from 8.2% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $26.9M trimmed.

  • Janney Montgomery Scott's largest Q4 2016 buy was State Street SPDR Portfolio Short Term Corporate Bond ETF: 1,603,784 shares worth $49M.
  • Janney Montgomery Scott added most to Vanguard Short-Term Corporate Bond ETF in Q4 2016, an estimated $22.4M increase.
  • Janney Montgomery Scott's biggest Q4 2016 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $26.9M.
  • Janney Montgomery Scott fully exited Invesco Dorsey Wright Basic Materials Momentum ETF in Q4 2016, selling an estimated $3.7M.
  • Janney Montgomery Scott's ten largest holdings make up 13% of its $6.63B portfolio in Q4 2016.
  • Janney Montgomery Scott opened 237 new positions and closed 79 in Q4 2016.
  • Janney Montgomery Scott's portfolio value rose 17% quarter-over-quarter to $6.63B.

Based on Janney Montgomery Scott's 13F filing for Q4 2016, filed 13 Feb 2017.